Company intelligence / Profile preview

Lifera

Riyadh, Riyadh Province, Saudi Arabiahelp.liferay.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lifera was established in June 2023 by Saudi Arabia’s Public Investment Fund to build national health resilience through local biopharma manufacturing. It focuses on vaccines, insulin, plasma therapeutics, monoclonal antibodies, cell/gene therapies and precision medicine. The company has signed major partnerships such as a deal with Novo Nordisk to locally manufacture semaglutide-based GLP‑1 treatments for obesity/diabetes management. It also acquired SAUDIBIO to scale up its local manufacturing capacity.

Therapeutic areas: Metabolic DisordersEndocrinologyRare DiseasesInfectious Diseases
Modalities: VaccinesInsulinPlasma therapeuticsMonoclonal antibodiesCell therapiesGene therapiesSmall moleculesBiologics
Industry: Contract Manufacturing Organization

Partnerships

Novo Nordisk – localization/manufacture of semaglutide-based drugs including Wegovy for obesity treatmentAdditional partnerships anticipated with global/local pharma companies per strategic mandate

Beyond the preview

Go deeper on Lifera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifera.

Explore the full profile